-
Location
-
29 Newbury Street, 3 Rd Floor, Boston, MA
-
Summary
-
The estimated value of insider holdings of Third Rock Ventures IV, L.P. is at least $214M dollars as of February 4, 2025. Third Rock Ventures IV, L.P. is the 10%+ Owner of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $178M. Third Rock Ventures IV, L.P. is the 10%+ Owner of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $36.7M.
-
Signature
-
/s/ Kevin Gillis, Chief Operating Officer of TRV GP IV, LLC, general partner of Third Rock Ventures GP IV, L.P., general partner of Third Rock Ventures IV, L.P.